EUVIMEDEUVIMED entdecken
Open Access · CC BY-ND 4.0

TREATMENT OUTCOMES OF GESTATIONAL TROPHOBLASTIC DISEASE, EXPERIENCE FROM SAUDI ARABIA

Muhammad Farooq Latif, Faisal Azam, Syed Hammad Hassan Tirmazy, Nedal Bukhari

Journal of Ayub Medical College Abbottabad · 2024

DOI: 10.55519/jamc-02-12695 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Ayub Medical College Abbottabad, 2024. Verfasst von Muhammad Farooq Latif und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Dubai Hospital, Dubai-UAE. Hauptthemen laut MEDLINE: Gestational Trophoblastic Disease, Methotrexate, Antineoplastic Combined Chemotherapy Protocols, Chorionic Gonadotropin. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This research aims to assess the treatment outcomes and chemotherapy duration required for the normalization of Human chorionic gonadotropin (HCG) levels in patients diagnosed with Gestational Trophoblastic Neoplasia (GTN), encompassing both benign and malignant forms of the condition.

Methods

This retrospective study included GTD patients treated with chemotherapy in a single oncology clinic from January 2016 to May 2022. Clinical data were gathered from electronic records of the patients.

Results

During the study period, a total of 24 patients diagnosed with GTD underwent chemotherapy, with a median age of 32 years (range: 18–51). Intramuscular Methotrexate was the primary single-agent chemotherapy utilized in 20 cases (83%) for low-risk disease, while the EMA-CO regimen was the predominant combination chemotherapy employed in 3 cases (13%) for high-risk disease. The median number of chemotherapy cycles administered was 2 (range: 1–16), with a median duration of 4 weeks (range: 1–16) required for Human chorionic gonadotropin (HCG) normalization. Approximately half of the patients (n=10, 47.5%) transitioned to second-line combination chemotherapy, with a median normalization duration of 4 months. Four patients (40%) subsequently received third-line combination chemotherapy using the EMA-CO regimen. Initial complete response was achieved in 11 patients (47%) with first-line treatment, while 10 patients (43%) required second-line chemotherapy and 4 patients (17%) necessitated third-line EMACO chemotherapy. Of the 24 patients, 22 achieved complete response, while 2 patients are currently undergoing treatment.

Conclusion

All patients successfully attained complete response with chemotherapy. The median duration of chemotherapy for achieving normalization of HCG was 4 weeks, equivalent to 2 cycles. Notably, only 4 patients necessitated third-line chemotherapy following single-agent chemotherapy in the first and second lines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gestational Trophoblastic DiseaseMethotrexateAntineoplastic Combined Chemotherapy ProtocolsChorionic GonadotropinHumansFemaleAdultPregnancyRetrospective StudiesSaudi ArabiaAdolescentTreatment OutcomeMiddle AgedYoung AdultEtoposideCyclophosphamideVincristineBleomycinDactinomycin

Stichwörter der Autor:innen

Gestational trophoblastic neoplasia; Gestational trophoblastic disease; Methotr…

Substanzen

MethotrexateChorionic GonadotropinEtoposideCyclophosphamideVincristineBleomycinDactinomycin

Autor:innen und Institutionen

  • Department of Medical Oncology, Dubai Hospital, Dubai-UAE.
  • Department of Medical Oncology, King Fahad Specialist Hospital, Dammam-Saudi Arabia.
  • Department of Medical Oncology, Prince Sultan Military Medical City, Riyadh-Saudi Arabia.

Zitieren

APA

Latif, M. F., Azam, F., Hassan Tirmazy, S. H., & Bukhari, N. (2024). TREATMENT OUTCOMES OF GESTATIONAL TROPHOBLASTIC DISEASE, EXPERIENCE FROM SAUDI ARABIA. Journal of Ayub Medical College Abbottabad. https://doi.org/10.55519/jamc-02-12695

Vancouver

Latif MF, Azam F, Hassan Tirmazy SH, Bukhari N. TREATMENT OUTCOMES OF GESTATIONAL TROPHOBLASTIC DISEASE, EXPERIENCE FROM SAUDI ARABIA. Journal of Ayub Medical College Abbottabad. 2024. doi:10.55519/jamc-02-12695

BibTeX
@article{Latif2024,
  author = {Latif, Muhammad Farooq and Azam, Faisal and Hassan Tirmazy, Syed Hammad and Bukhari, Nedal},
  title = {TREATMENT OUTCOMES OF GESTATIONAL TROPHOBLASTIC DISEASE, EXPERIENCE FROM SAUDI ARABIA},
  journal = {Journal of Ayub Medical College Abbottabad},
  year = {2024},
  doi = {10.55519/jamc-02-12695}
}
Kostenlos starten →